- Home
- SLG vs TXG Comparison
SLG vs TXG Comparison
Compare SLG & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLG | TXG |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | United States | United States |
| Employees | 1289 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.6B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SLG | TXG |
|---|---|---|
| Price | $50.71 | $34.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 15 |
| Target Price | ★ $50.63 | $20.25 |
| AVG Volume (30 Days) | 1.0M | ★ 3.1M |
| Earning Date | 04-15-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.29% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $34.77 | $10.51 |
| 52 Week High | $66.29 | $35.65 |
Technical Indicators
Market Signals| Indicator | SLG | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 64.30 | 70.12 |
| Support Level | $50.05 | $16.11 |
| Resistance Level | $52.48 | $35.65 |
| Average True Range (ATR) | 1.80 | 2.41 |
| MACD | 0.12 | 0.21 |
| Stochastic Oscillator | 77.16 | 88.10 |
Price Performance
Historical ComparisonAbout SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 31.4 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).